Amerise Biosciences Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 6.61 Cr
as on 16-11-2024
- Company Age 40 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.84 M
as on 16-11-2024
- Revenue -99.91%
(FY 2023)
- Profit -121.65%
(FY 2023)
- Ebitda -529.61%
(FY 2023)
- Net Worth -2.11%
(FY 2023)
- Total Assets -52.89%
(FY 2023)
About Amerise Biosciences
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 531681.
The Corporate was formerly known as Amradeep Industries Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 6.61 Cr.
The company currently has active open charges totaling ₹3.84 M.
The Key Managerial Personnel (KMP) at Amerise Biosciences Limited India are Dineshkumar Rathod as CFO and Minal Lakhlani as Company Secretary. Dineshkumar Rathod, Niraj Vaghela, and Manisha Maneklal serve as directors at the Company.
- CIN/LLPIN
L29199GJ1984PLC007195
- Company No.
007195
- Stock Symbol
BSE : 531681
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Aug 1984
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Amerise Biosciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dineshkumar Rathod | CFO | 22-Nov-2021 | Current |
| Minal Lakhlani | Company Secretary | 12-Nov-2021 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dineshkumar Rathod  | Whole-Time Director | 22-Nov-2021 | Current |
| Niraj Vaghela | Director | 22-Jul-2022 | Current |
| Manisha Maneklal | Director | 24-Jun-2019 | Current |
Financial Performance and Corporate Structure Insights of Amerise Biosciences.
Amerise Biosciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.91% decrease. The company also saw a substantial fall in profitability, with a 121.65% decrease in profit. The company's net worth dipped by a decrease of 2.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amerise Biosciences?
In 2022, Amerise Biosciences had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Amraworld Agrico LimitedActive 33 years 6 monthsDineshkumar Rathod, Niraj Vaghela and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 17 Mar 1987 | ₹0.90 M | Open |
Gujarat State Financial Corporation Creation Date: 20 Aug 1985 | ₹2.94 M | Open |
How Many Employees Work at Amerise Biosciences?
Unlock and access historical data on people associated with Amerise Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amerise Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amerise Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
